Navigation Links
Strativa Pharmaceuticals Signs Agreement With Swedish Orphan Biovitrum Regarding Nascobal®
Date:10/26/2010

WOODCLIFF LAKE, N.J., Oct. 26 /PRNewswire/ -- Strativa Pharmaceuticals today announced that it has entered into an amended and restated license and supply agreement with Swedish Orphan Biovitrum (Sobi) covering the European development and commercialization rights of Strativa's Nascobal (cyanocobalamin) Vitamin B12 Nasal Spray.  Strativa acquired the worldwide rights to Nascobal from QOL Medical, LLC in March 2009, which included a pre-existing agreement with Sobi.    

Under the terms of the amended agreement, Sobi will conduct and pay for all development activities for European regulatory approval of Nascobal.  Sobi is expected to begin clinical development in the first half of 2011.  Strativa and Sobi will share in the expense of upgrading Strativa's manufacturing facility to comply with European regulations, and Strativa will supply European-ready product to Sobi.  Sobi will be responsible for commercializing the product in Europe, including all sales and marketing activities.  Strativa will receive double-digit royalty payments based on Sobi's net sales of Nascobal in Europe.  

Nascobal Nasal Spray is a US FDA approved prescription vitamin B12 supplement indicated to treat vitamin B12 deficiency.  It is the first and only once-weekly, self-administered alternative to B12 injections.  The leading causes of vitamin B12 deficiency include pernicious anemia, a strict vegetarian diet, malabsorption of vitamin B12 resulting from conditions such as HIV infection, Crohn's disease, multiple sclerosis and partial or total gastrectomy, among others.  In 2009, more than 48 million and 72 million vitamin B12 injections were prescribed to patients in the United States and Europe, respectively, according to IMS Health.

Nascobal Nasal Spray Safety Information

Nascobal® Nasal Spray is indicated for the maintenance of normal hematologic status in pernicious anemia patients who are i
'/>"/>

SOURCE Strativa Pharmaceuticals
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. FDA Approves Strativa Pharmaceuticals Zuplenz® (ondansetron) Oral Soluble Film
2. Strativa Pharmaceuticals Provides An Update On Zuplenz(R) (Ondansetron) Oral Soluble Film
3. Strativa Pharmaceuticals Development Partner, BioAlliance Pharma, Presents Phase III Study Results of Miconazole Lauriad(R) for the Treatment of Oropharyngeal Candidiasis
4. Strativa Pharmaceuticals Provides Product Pipeline Update
5. Strativa Pharmaceuticals Announces Preliminary Results from ONCONASE(R) Phase IIIb Clinical Trial
6. Strativa Pharmaceuticals Announces Phase III Results for Loramyc(R) to Treat Oropharyngeal Candidiasis
7. Keryx Biopharmaceuticals Announces Completion of Patient Enrollment In Zerenex Phase 3 Short-Term Study
8. Celtic Therapeutics and Resolvyx Pharmaceuticals Announce an Alliance in Ophthalmology
9. Savient Pharmaceuticals to Hold Conference Call on October 26, 2010 at 8:30 a.m. Eastern Time
10. Savient Pharmaceuticals Provides Update on Strategic Alternatives Process
11. Optimer Pharmaceuticals Announces Combined Data From Fidaxomicin Phase 3 Trials for the Treatment of Clostridium difficile Infection (CDI) Presented at IDSA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... y LONDRES, 28 de agosto de 2015 ... anunció hoy su participación en el  Congreso de ... soluciones cardiológicas más recientes y novedosas, entre ellas ... conectan a las personas y la tecnología con ... a diagnosticar, guiar los tratamientos y permitir atención ...
(Date:8/28/2015)... August 28, 2015 The global ... USD 49.12 billion by 2020, growing at a CAGR ... new report by Grand View Research, Inc. Monitoring services ... 49.7% from 2014 to 2020.      (Logo: ... along with rising incidences of chronic diseases such as ...
(Date:8/27/2015)... , Aug. 27, 2015  A recent study ... Knee Journal, compared the Arthrosurface HemiCAP® Wave implant, ... versus an "onlay" design implant for isolated patellofemoral ... in function and pain scores, none of the ... osteoarthritis (OA). However, 53% of the patients in ...
Breaking Medicine Technology:Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 2Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 3Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 4Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 5mHealth Market is Expected to Reach $49.12 Billion By 2020: Grand View Research, Inc. 2mHealth Market is Expected to Reach $49.12 Billion By 2020: Grand View Research, Inc. 3mHealth Market is Expected to Reach $49.12 Billion By 2020: Grand View Research, Inc. 4mHealth Market is Expected to Reach $49.12 Billion By 2020: Grand View Research, Inc. 5Study Demonstrates Dramatic Reduction in Progression of Osteoarthritis with the Arthrosurface "Inlay" Patellofemoral Implant Design Compared to Traditional "Onlay" Implant 2Study Demonstrates Dramatic Reduction in Progression of Osteoarthritis with the Arthrosurface "Inlay" Patellofemoral Implant Design Compared to Traditional "Onlay" Implant 3
... HeartWare International, Inc. (Nasdaq: HTWR ; ASX: ... support technologies that are revolutionizing the treatment of advanced ... scheduled to make an investor presentation at the 29th ... Time on Monday, January 10, 2011. The conference is ...
... MOUNTAIN VIEW, Calif., Jan. 4, 2011 MAP Pharmaceuticals, Inc. ... will present at the 29th Annual J.P. Morgan Healthcare Conference ... San Francisco. A live webcast of the ... MAP Pharmaceuticals, website at http://www.mappharma.com . A replay will ...
Cached Medicine Technology:HeartWare to Present at the 29th Annual J.P. Morgan Healthcare Conference 2
(Date:8/28/2015)... ... 28, 2015 , ... SharkNinja, an innovative leader in the ... actress, Sofia Vergara, and unveil the Ninja® brand’s new coffee machine, the ... a variety of sizes and styles while achieving the perfect brew richness level ...
(Date:8/28/2015)... ... 28, 2015 , ... United Benefit Advisors (UBA), the nation’s ... as its newest Partner Firm. Founded in 1924 and headquartered in Pittsburgh, Pennsylvania, ... their goals. Within the past 10 years, TJS Insurance Group has emerged as ...
(Date:8/28/2015)... Knoxville, TN (PRWEB) , ... August 28, 2015 , ... ... surrounding the Centers for Medicare & Medicaid Services’ (CMS) proposal to mandate bundled ... 45-minute webinar , “Get Ready for Game Day: Comprehensive Care for Joint Replacement,” ...
(Date:8/28/2015)... (PRWEB) , ... August 28, 2015 , ... Santa Rosa ... to Work in Healthcare by Modern Healthcare. In the KLAS “2015 Midterm Performance Review: ... , “We believe the recognitions from Modern Healthcare and KLAS are directly related ...
(Date:8/27/2015)... Caicos Islands, BWI (PRWEB) , ... August 28, 2015 , ... ... for weddings. This award is added to an already impressive list of accolades ... Grace Bay was ranked as the #2 beach in the world by TripAdvisor, the ...
Breaking Medicine News(10 mins):Health News:Sofia Vergara Partners With SharkNinja® To Launch The Ninja Coffee Bar™ 2Health News:Sofia Vergara Partners With SharkNinja® To Launch The Ninja Coffee Bar™ 3Health News:TJS Insurance Group Is Latest Partner Firm To Join United Benefit Advisors 2Health News:TJS Insurance Group Is Latest Partner Firm To Join United Benefit Advisors 3Health News:PYA Offers Complimentary CCJR Webina — Game On 2Health News:PYA Offers Complimentary CCJR Webina — Game On 3Health News:Santa Rosa Consulting Recognized by Modern Healthcare as One of the Top 100 Best Places to Work and from KLAS Research with the Highest Rating for Go-Live Support 2Health News:Grace Bay Beach Acknowledged as a Top Caribbean Beach for Weddings 2
... in the recent years. But a new study has found ... took such vows. // ,The study also questions ... gauging how well they adhere to these pledges, reports foodconsumer.org. ... or written declarations to remain a virgin until marriage. ...
... in the arm for researchers of biological intelligence in the ... resemble a baby infant’s learning process, aided by it’s ... roboticists from Italy, France and Switzerland, is an ingenious effort ... similar manner of experimenting with objects available, and imbibing the ...
... the US it was found that the condition has fast ... disorder that is afflicting an estimated 300,000 U.S. schoolchildren, or ... estimate contraindicates with the estimate of 1 in every 2,000 ... about an argument as to whether the higher prevalence reflects ...
... as a beneficial and healthy activity. With the emphasis slowly, ... there’s nothing like a bit of gardening to rev up ... Institute at Northwestern Memorial Hospital in Chicago says that the ... when you bend down at your knees. "It's going to ...
... Syndrome or the shaking leg syndrome is a common type of ... their legs//. For the first time Europe has approved the drug ... and causes aches and pains. Statistics show that about 10% of ... was given by the European Medicines Agency. As of now it ...
... non-hormonal male contraceptive device that targets sperms, called Intra Vas ... study// involving 90 men. Men and women have long been ... this first male contraceptive to be marketed market may not ... place in Seattle, Washington and St. Paul, Minnesota, will bring ...
Cached Medicine News:Health News:Teenagers Often Deny Taken ‘Virginity Pledges 2Health News:Burn Away Calories In Your Garden 2Health News:Non-Hormonal Male Contraceptive Based on Sperm Block Underway 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: